New tools for modifying DNA and RNA nucleobases
DNAzymes for Site-Specific DNA and RNA Nucleobase Modification
This study is exploring new tools called DNAzymes that can change specific parts of DNA and RNA, which could help scientists better understand how these changes affect our bodies and lead to exciting new uses in medicine and technology.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10901830 on NIH RePORTER |
What this research studies
This research focuses on developing innovative DNAzymes, which are artificial DNA sequences that can perform specific modifications on DNA and RNA nucleobases. By using a method called in vitro selection, researchers aim to create DNAzymes that can efficiently modify long nucleic acid substrates, overcoming current limitations in synthesizing modified nucleic acids. This approach could enhance our understanding of the biochemical and biological roles of nucleobase modifications, potentially leading to new applications in biotechnology and medicine.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with genetic conditions or diseases that could benefit from targeted DNA or RNA modifications.
Not a fit: Patients with conditions unrelated to DNA or RNA modifications may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to advanced techniques for modifying DNA and RNA, which may improve therapeutic strategies and diagnostic tools.
How similar studies have performed: While DNAzymes have shown promise in various applications, this specific approach to nucleobase modification is relatively novel and has not been extensively tested.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Silverman, Scott K — University of Illinois at Urbana-Champaign
- Study coordinator: Silverman, Scott K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.